CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement

Leuk Lymphoma. 2021 Apr;62(4):861-867. doi: 10.1080/10428194.2020.1849678. Epub 2020 Nov 25.

Abstract

Platelet/endothelial cell adhesion molecule 1 (PECAM-1, CD31) is an immunoglobulin superfamily member expressed on the surface of platelets, leukocytes and endothelial cells. The role of CD31 in biology of lymphomas has not yet been systemically studied. Expression of cell surface CD31 was analyzed by flow cytometry on primary MCL cells isolated from peripheral blood, bone marrow or malignant effusions obtained from 29 newly diagnosed MCL patients. CD31 was significantly more expressed in patients with documented extranodal involvement. Knock-down of CD31 expression in JEKO1 and MINO MCL cell lines hampered their subcutaneous engraftment in immunodeficient mice and prolonged overall survival of intravenously-xenografted animals. In contrast, transgenic overexpression of CD31 accelerated growth of subcutaneous JEKO1 and MINO tumors, shortened overall survival of intravenously-xenografted mice, and resulted in significantly increased frequency of extramedullary murine tissue infiltration Our observations suggest that CD31 facilitate survival and regulate extranodal spread of MCL cells.

Keywords: CD31/PECAM-1; angiogenesis; extranodal involvement; mantle cell lymphoma; xenografts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Animals
  • Blood Platelets
  • Bone Marrow
  • Endothelial Cells
  • Humans
  • Lymphoma, Mantle-Cell* / genetics
  • Mice
  • Platelet Endothelial Cell Adhesion Molecule-1 / genetics

Substances

  • PECAM1 protein, human
  • Platelet Endothelial Cell Adhesion Molecule-1